Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07088601Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in post-spinal shivering (PSS) comparing Ondansetron Group with Placebo Group (2 arms). Primary endpoint: Incidence of shivering. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07088601.